Oleksandr Doskalchuk, who wore flyweight gold for M-1, has been waiting months to make his UFC debut, with two fights falling through in July. Now, he’ll be waiting even longer, after having been handed down a 14-month suspension by USADA (the U.S. Anti-Doping Agency) for a violation of the UFC’s Anti-Doping Policy.
USADA officials announced the news in a press release Wednesday.
Doskalchuk (10-2) tested positive for the mesterolone metabolites in an urine sample collected out-of-competition on June 6, 2020. His promotional debut, initially against Tagir Ulanbekov and later Malcolm Gordon, had been scheduled for the following month.
Mesterolone is banned at all time under the UFC’s anti-doping policy, and falls under the category of anabolic agents. In his defense, Doskalchuk “provided evidence that a physician incorrectly prescribed him a prohibited medication containing mesterolone despite the fact that Doskalchuk sent him the UFC Wallet Card and requested treatment permitted under the rules,” USADA revealed in Wednesday’s press release.
As a result, he became eligible for a reduced sentence. In addition, Doskalchuk received an additional reduction in his sanction for his cooperation during the investigation.
Doskalchuk’s 14-month period of ineligibility dates back to June 6, when his positive sample was provided. The 30-year old has not fought since November of 2018.
